Bioethical Dilemmas

Why This Matters

Bioethics sits at the intersection of philosophy's biggest questions: What gives life value? Who gets to make decisions about bodies and health? How do we balance individual freedom against collective welfare? When you encounter bioethical dilemmas on an exam, you're being tested on your ability to apply core ethical frameworks — utilitarianism, deontology, virtue ethics, and care ethics — to real-world scenarios where these theories often conflict. These aren't abstract puzzles; they're the exact situations doctors, policymakers, and families face every day.

What makes bioethics particularly challenging is that reasonable people using sound ethical reasoning can reach opposite conclusions. An FRQ might ask you to defend both sides of an abortion debate or explain why a utilitarian and a Kantian would disagree about genetic enhancement. The key is understanding which principles are in tension: autonomy vs. beneficence, individual rights vs. social good, sanctity of life vs. quality of life. Don't just memorize positions; know what ethical concept each dilemma illustrates and be ready to argue multiple perspectives.

---

Autonomy and Bodily Self-Determination

These dilemmas center on a foundational question: Who has the right to make decisions about a person's own body? The principle of autonomy holds that competent individuals should control what happens to them, but this right frequently collides with other moral claims: the interests of potential life, family members, or society at large.

Abortion and Reproductive Rights

The central philosophical question is personhood and moral status: when does a fetus acquire rights that might override maternal autonomy? Different frameworks draw this line at conception, viability, birth, or other developmental milestones, and where you draw it shapes everything else in the debate.

• Bodily autonomy arguments draw on Judith Jarvis Thomson's famous violinist thought experiment, which separates the question of fetal personhood from the question of whether anyone can be compelled to sustain another life with their body. Even if the fetus is a person, Thomson argues, mandatory pregnancy doesn't automatically follow.
• Legal and ethical divergence is striking here. What's legally permitted varies enormously across jurisdictions, demonstrating how different societies weigh competing values. A practice can be legal yet ethically contested, or illegal yet ethically defensible, depending on the framework you apply.

Euthanasia and Assisted Suicide

These terms describe distinct moral categories. Voluntary euthanasia means a physician directly administers death at the patient's request. Assisted suicide means a physician provides the means but the patient performs the final act. This distinction matters because it shifts who bears moral responsibility for the death itself.

• Right to die with dignity arguments invoke autonomy: if you control your own body, that control should extend to how and when you die. Opponents cite the sanctity of life and worry about vulnerable populations (elderly, disabled, economically disadvantaged) feeling pressured to choose death rather than be "burdens."
• Slippery slope concerns are prominent in this debate. Critics argue that permitting assisted death in narrow circumstances will gradually erode protections, expanding eligibility until people who aren't truly autonomous end up dying. Defenders counter that decades of data from places like Oregon and the Netherlands show these safeguards can hold.

Informed Consent in Medical Procedures

Informed consent is autonomy in action. The principle of respect for persons requires that patients understand the risks, benefits, and alternatives before agreeing to treatment.

• Capacity and competence create complications. What happens when patients are minors, cognitively impaired, or unconscious in an emergency? In these cases, someone else must decide, and the ethical justification shifts from autonomy to beneficence.
• Cultural and structural barriers can undermine genuine consent even when forms are signed. Language differences, power imbalances between doctor and patient, and time pressures in busy hospitals all mean that a signature doesn't always equal understanding.

---

Beginning and End of Life

These dilemmas force us to confront the boundaries of moral consideration: When does a human life begin to matter morally? When, if ever, does it stop mattering? Different ethical frameworks draw these lines in radically different places.

Stem Cell Research

The crux of this debate is the moral status of embryos. Are they full persons with rights? Potential persons deserving some respect? Or biological material with no independent moral claims?

• Embryonic vs. adult stem cells present different ethical tradeoffs. Embryonic stem cells have greater therapeutic potential (they can become any cell type) but require destroying embryos. Adult stem cells and induced pluripotent stem cells (iPSCs) avoid this problem but have been more limited in application.
• A consequentialist defense emphasizes the millions who could benefit from regenerative medicine, weighing aggregate welfare against the destruction of embryos that would otherwise be discarded from fertility clinics anyway. A deontologist might counter that using embryos as mere means violates their dignity regardless of the benefits.

Human Cloning

The reproductive vs. therapeutic cloning distinction matters ethically. Reproductive cloning (creating a new individual) raises different concerns than therapeutic cloning (creating tissue or organs for medical treatment without producing a person).

• Identity and individuality concerns ask whether clones would be psychologically harmed by expectations that they replicate their genetic source, or treated as means rather than ends. Kant's categorical imperative is directly relevant here.
• Near-universal legal prohibition of reproductive cloning reflects broad societal consensus that some biotechnologies cross moral boundaries. Interestingly, many people hold this intuition strongly even when they struggle to articulate a precise philosophical justification for it.

End-of-Life Care and Decision-Making

• Advance directives allow individuals to extend their autonomous choices into periods when they can no longer communicate. This concept of precedent autonomy raises a tricky question: should your past self's wishes bind your present self if your values or condition have changed in ways you didn't anticipate?
• Quality vs. quantity of life is where frameworks clash most visibly. A utilitarian might calculate that prolonging a life filled with suffering produces net harm, while a deontologist might insist that life has intrinsic value that can't be reduced to a pain-pleasure calculation.
• Surrogate decision-making raises questions about whose values should guide choices when patients cannot speak for themselves. Should surrogates follow what the patient would have wanted (substituted judgment) or what seems objectively best (best interest standard)?

---

Justice and Resource Allocation

When resources are scarce, bioethics becomes explicitly political. Who gets access to life-saving treatments? How do we distribute the benefits and burdens of medical progress fairly? These dilemmas test your understanding of distributive justice theories.

Healthcare Resource Allocation

Triage forces explicit choices about whose life to prioritize. Different theories of justice produce different answers.

• A utilitarian approach maximizes total lives saved or total life-years gained. An egalitarian approach emphasizes equal moral worth and may prioritize the worst-off. A libertarian approach might let ability to pay determine access.
• QALYs (Quality-Adjusted Life Years) attempt to quantify health outcomes by combining length of life with quality of life into a single metric. Critics argue QALYs can devalue disabled lives by rating their quality lower, building ableist assumptions into supposedly neutral calculations.
• Socioeconomic determinants mean that "neutral" allocation criteria often reproduce existing inequalities. If you allocate by likelihood of survival, and survival correlates with wealth, your "fair" system may systematically disadvantage the poor.

Organ Donation and Transplantation

• Opt-in vs. opt-out systems reflect different assumptions about default consent. Countries with opt-out systems (where you're a donor unless you say otherwise) have dramatically higher donation rates than opt-in systems. This raises questions about whether default settings manipulate choice or simply reflect what most people would want.
• Allocation criteria must balance medical urgency, likelihood of success, time on the waiting list, and geographic factors. Each choice embeds ethical assumptions about what matters most.
• Living donation and financial incentives introduce further questions. Is it acceptable for a healthy person to risk surgery to donate a kidney? Would paying donors help solve the organ shortage, or would it exploit the economically desperate and commodify the human body?

Vaccination and Public Health

• Herd immunity creates a collective action problem. When enough people are vaccinated, even those who can't be vaccinated (infants, immunocompromised individuals) gain protection. But each individual has an incentive to free-ride on others' vaccination while avoiding personal risk.
• Mandatory vaccination pits public health beneficence against individual liberty. This is a classic tension in political philosophy: John Stuart Mill's harm principle suggests liberty can be restricted to prevent harm to others, but how direct and severe must the harm be to justify coercion?
• Global vaccine equity exposes how national borders complicate utilitarian calculations. If the goal is maximizing worldwide welfare, wealthy nations stockpiling vaccines while poorer nations go without is hard to justify on consequentialist grounds.

---

Technology and Human Enhancement

As biotechnology advances, we face unprecedented questions: Should we use technology only to restore "normal" function, or is enhancement permissible? Who decides what counts as "normal"? These dilemmas test whether traditional ethical categories can handle radical technological change.

Genetic Engineering and Gene Therapy

• Somatic vs. germline editing is a critical distinction. Somatic changes affect only one individual and aren't inherited. Germline modifications (like those made possible by CRISPR-Cas9) pass to future generations who cannot consent to the alteration. This raises questions about intergenerational ethics that most traditional frameworks weren't designed to address.
• The therapy vs. enhancement distinction is philosophically unstable. Correcting a gene that causes cystic fibrosis seems clearly therapeutic. Enhancing memory or intelligence seems clearly enhancement. But what about correcting genetic deafness in a community where Deaf culture is valued? The line between "fixing a deficiency" and "improving beyond normal" depends on contested assumptions about what counts as normal.
• "Playing God" objections invoke concerns about human hubris and overstepping natural boundaries. Critics of this objection note that medicine has always intervened in nature; antibiotics, surgery, and vaccines all alter "natural" outcomes. The question is whether genetic engineering differs in kind or merely in degree.

Human Enhancement Technologies

• The positional goods problem is one of the strongest objections to enhancement. If cognitive or physical enhancements provide competitive advantages in school or work, non-enhanced individuals are disadvantaged. Over time, this could create coercive pressure to enhance, undermining the very autonomy that's supposed to justify the choice.
• Authenticity concerns ask whether enhanced achievements are truly "yours." If a drug boosts your exam performance, did you earn that grade? This connects to virtue ethics: does enhancement undermine the character development that comes from genuine effort and struggle?
• Transhumanist arguments embrace enhancement as continuous with medicine's traditional goals. If medicine already aims to reduce suffering and expand human capability, transhumanists argue there's no principled reason to stop at "normal" functioning.

Artificial Intelligence in Healthcare

• Algorithmic bias can encode and amplify existing healthcare disparities. If an AI diagnostic tool is trained primarily on data from one demographic group, it may perform poorly for others, systematically disadvantaging already-marginalized populations.
• Accountability gaps emerge when AI makes diagnostic errors. Who bears responsibility: the physician who relied on the recommendation, the hospital that adopted the system, or the developers who built it? Traditional medical liability frameworks assume a human decision-maker.
• Epistemic concerns arise when AI "black boxes" make recommendations that even experts cannot fully explain. Informed consent requires that patients understand their treatment, but how can a doctor explain a diagnosis that even the doctor can't fully trace?

---

Privacy, Trust, and Professional Obligations

Healthcare depends on trust between patients and providers. These dilemmas explore the boundaries of confidentiality, the ethics of medical research, and how professional obligations sometimes conflict with other values.

Confidentiality and Privacy in Medical Records

Therapeutic trust requires patients to share sensitive information honestly. If patients fear their information will be disclosed, they may withhold details or avoid seeking care entirely, which harms both the individual and public health.

• Limits to confidentiality exist when third parties face serious harm. The landmark Tarasoff v. Regents case established a duty to warn when a patient poses a credible threat to an identifiable person. This forces a direct tradeoff between patient privacy and preventing harm.
• Digital health data creates new vulnerabilities. Electronic records can be hacked, sold to third parties, or subpoenaed in legal proceedings in ways paper records could not. The scale and permanence of digital data amplify privacy risks considerably.

Animal Testing in Medical Research

The moral status of animals is the foundational question. Your answer depends heavily on your ethical framework.

• A utilitarian like Peter Singer weighs animal suffering against human benefits and may support testing only when the expected gains clearly outweigh the harm. A rights-based approach (Tom Regan) may oppose testing regardless of outcomes, arguing that animals have inherent value that can't be overridden by human interests.
• The Three Rs framework (Replace, Reduce, Refine) represents a practical ethical compromise. It accepts some animal research while pushing scientists to find alternatives, use fewer animals, and minimize suffering. Most institutional review processes now require adherence to these principles.
• Regulatory requirements often mandate animal testing before human trials can begin, creating institutional pressure that individual researchers cannot easily escape even if they have moral objections.

Surrogacy and Reproductive Technologies

• Commodification concerns ask whether paying surrogates inappropriately treats reproduction as a market transaction. If pregnancy can be bought and sold, does that reduce something deeply human to a commercial service?
• Exploitation vs. autonomy is the central tension. Critics worry that surrogates (often from lower socioeconomic backgrounds or developing countries) face economic coercion that undermines genuine free choice. Defenders emphasize women's right to make their own reproductive decisions and argue that banning surrogacy is paternalistic.
• Parentage and rights become legally complex when genetic, gestational, and intended parents are all different people. Who counts as the "real" parent? Different jurisdictions answer this differently, and the legal uncertainty itself creates ethical risk for all parties involved.

---

Quick Reference Table

---

Self-Check Questions

1. Both abortion and euthanasia invoke autonomy. What key difference makes the abortion debate more complex regarding third-party interests?

2. Identify two bioethical dilemmas where the therapy vs. enhancement distinction is central to the ethical debate. Why is this distinction philosophically unstable?

3. Compare and contrast how a utilitarian and a Kantian deontologist would approach mandatory vaccination policies. Which principles does each prioritize?

4. Healthcare resource allocation and organ donation both involve distributing scarce medical resources. What unique ethical consideration does organ donation add that allocation decisions during a pandemic do not?

5. If an FRQ asked you to evaluate whether genetic engineering represents "playing God," what ethical framework would you use to defend the practice, and what framework would best support opposition? Explain the key principles each side would invoke.